Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement
Crossref DOI link: https://doi.org/10.1186/s12885-017-3487-y
Published Online: 2017-07-25
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Dan-Juan
Xiao, Dong
Funding for this research was provided by:
the National Natural Science Foundation of China (NSFC) (81101535)
